Stoke Therapeutics Inc
STOK
Market Cap$511.03M
Close$
$-2.84
130.3% downside
Current Fair Value
130.3% downsideOvervalued by 130.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $511.03 Million |
|---|---|
| Enterprise Value | $404.36 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-1.65 |
| Beta | 1.2 |
| Outstanding Shares | 57,029,296 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -6 |
|---|---|
| PEG | -77.98 |
| Price to Sales | - |
| Price to Book Ratio | 2.34 |
| Enterprise Value to Revenue | 24.15 |
| Enterprise Value to EBIT | -3.41 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0.05 |
| Debt to Equity | 0.09 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Stoke Therapeutics Inc
CEO: Edward Kaye